For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

 

Crossref Citations

1. Bite-to-needle Time – An Extrapolative Indicator of Repercussion in Patients with Snakebite
Thamizhkumaran Jayaraman, Raju Dhanasinghu, Santhanam Kuppusamy, Archana Gaur, Varatharajan Sakthivadivel
Indian Journal of Critical Care Medicine  vol: 26  issue: 11  first page: 1175  year: 2022  
doi: 10.5005/jp-journals-10071-24344

2. Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
Tommaso C. Bulfone, Stephen P. Samuel, Philip E. Bickler, Matthew R. Lewin
Journal of Tropical Medicine  vol: 2018  first page: 1  year: 2018  
doi: 10.1155/2018/4320175

3. Dermonecrosis caused by a spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib
Keirah E. Bartlett, Steven R. Hall, Sean A. Rasmussen, Edouard Crittenden, Charlotte A. Dawson, Laura-Oana Albulescu, William Laprade, Robert A. Harrison, Anthony J. Saviola, Cassandra M. Modahl, Timothy P. Jenkins, Mark C. Wilkinson, José María Gutiérrez, Nicholas R. Casewell
Proceedings of the National Academy of Sciences  vol: 121  issue: 19  year: 2024  
doi: 10.1073/pnas.2315597121

4. Heparin-incorporated whey protein isolate-derived hydrogels with an intended dual function as snakebite wound dressings and drug delivery systems inhibit spitting cobra venom-induced cytotoxicity
Matthew J. Gray, Daniel K. Baines, Gabrielle De Castro, Thomas Cobb, Layla A. Tyrrell, Sam J. Hyam, Alan M. Smith, Nicholas R. Casewell, Sarah L. Allinson, Timothy E.L. Douglas, Steven R. Hall
Toxicon  vol: 275  first page: 109061  year: 2026  
doi: 10.1016/j.toxicon.2026.109061

5. Identification of DC-174 as a Novel Hydroxamic Precandidate for the Development of an Oral Snakebite Treatment
Daniel J. W. Chong, Laura-Oana Albulescu, Adam Westhorpe, Rachel H. Clare, Amy E. Marriott, Christopher M. Woodley, Ramachandran Gunasekar, Nada Mosallam, Edouard Crittenden, Emma Stars, Charlotte Dawson, Jeroen Kool, Mark C. Wilkinson, Suet C. Leung, Neil G. Berry, Nicholas R. Casewell, Paul M. O’Neill
Journal of Medicinal Chemistry  vol: 69  issue: 8  first page: 9386  year: 2026  
doi: 10.1021/acs.jmedchem.6c00064

6. Optimizing drug discovery for snakebite envenoming via a high-throughput phospholipase A2 screening platform
Laura-Oana Albulescu, Adam Westhorpe, Rachel H. Clare, Christopher M. Woodley, Nivya James, Jeroen Kool, Neil G. Berry, Paul M. O’Neill, Nicholas R. Casewell
Frontiers in Pharmacology  vol: 14  year: 2024  
doi: 10.3389/fphar.2023.1331224

7. Epidemiology, ecology and human perceptions of snakebites in a savanna community of northern Ghana
Yahaya Musah, Evans P. K. Ameade, Daniel K. Attuquayefio, Lars H. Holbech, Jean-Philippe Chippaux
PLOS Neglected Tropical Diseases  vol: 13  issue: 8  first page: e0007221  year: 2019  
doi: 10.1371/journal.pntd.0007221

8. Repurposed drugs and their combinations prevent morbidity-inducing dermonecrosis caused by diverse cytotoxic snake venoms
Steven R. Hall, Sean A. Rasmussen, Edouard Crittenden, Charlotte A. Dawson, Keirah E. Bartlett, Adam P. Westhorpe, Laura-Oana Albulescu, Jeroen Kool, José María Gutiérrez, Nicholas R. Casewell
Nature Communications  vol: 14  issue: 1  year: 2023  
doi: 10.1038/s41467-023-43510-w